[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100553235":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":16,"locations":10,"responsibleParty":21,"collaborators":10,"id":24,"slug":10,"hasResults":25,"nctId":26,"briefTitle":27,"officialTitle":28,"acronym":10,"eligibilityCriteria":29,"healthyVolunteers":25,"sex":30,"minAge":31,"maxAge":10,"enrollmentInfo":32,"targetDuration":35,"studyType":36,"phases":10,"briefSummary":37,"conditions":38,"keywords":40,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":10},{"fullName":5,"class":6},"State University of New York at Buffalo","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":10},"Individuals with active HCV infection",null,[12],{"name":13,"affiliation":14,"role":15},"Andrew H Talal, MD, MPH","University at Buffalo","PRINCIPAL_INVESTIGATOR",[17],{"name":13,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","7168293101","ahtalal@buffalo.edu",{"type":15,"investigatorFullName":22,"investigatorTitle":23,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Andrew Talal","Professor of Medicine","100553235",false,"NCT06483451","Facilitated Telemedicine in the Catholic Health System","Hepatitis C Virus Management Through Facilitated Telemedicine Integrated Into Opioid Treatment Programs: Catholic Health System Experience","Inclusion Criteria:\n\n* evidence of active HCV infection\n\nExclusion Criteria:\n\n* no evidence of active HCV infection","ALL","18 Years",{"count":33,"type":34},200,"ESTIMATED","2 Years","OBSERVATIONAL","Hepatitis C virus is a leading cause of morbidity and mortality globally with the highest prevalence and incidence among people with opioid use disorder. We aim to establish facilitated telemedicine as a standard of care treatment approach at 3 opioid treatment programs operated by the Catholic Health System. This study is a chart review data analysis to evaluate outcomes of facilitated telemedicine integrated into opioid treatment programs and to evaluate the number of individuals who initiate and complete treatment for hepatitis C virus infection.",[39],"HCV",[41],"telemedicine","NOT_YET_RECRUITING","2026-02-03",{"date":45,"type":46},"2026-02-05","ACTUAL",{"date":48,"type":34},"2026-07",{"date":50,"type":34},"2026-12",{"name":5,"class":6}]